Dr. Ravi Kant Gupta specialized in Nuclear Medicine and hold the Senior Consultant designation.
Qualifications
MBBS (Seth GSMC & KEMH, Mumbai)
MD (AIIMS, New Delhi)
FANMB (Fellow of Asian Nuclear Medicine Board)
Experience
Specialized from AIIMS, New Delhi (6 years)
10 years of extensive experience in Nuclear Medicine & PET-CT with multiple diagnostic & Therapeutic procedures
Specialist in Gamma Imaging including SPECT-CT with various modalities & tracers (MDP, LLEC, DTPA, DMSA, HIDA, ECD, TRODAT, Sestamibi, Cardiac MPI including Thallium and Tc-99m MIBI, MUGA, VQ scans)
Expertise in analysis & research in PET-CT studies with various PET tracers (F-18 FDG, Ga-68 PSMA, F-18 PSMA, Ga-68 DOTANOC, F-18 DOPA , FES, and others)
Experience with PET-CT guided biopsy
Experienced with Theranostic procedures including I-131 therapy & Redifferentiation therapy in thyroid cancer, I-131 MIBG therapy in Neuroendocrine tumours, Rhenium-188 for synovectomy, Samarium and Lu-177 EDTMP therapy for bone pain palliation, Lu-177 DOTATATE therapy for Neuroendocrine tumours, Lu-177 PSMA therapy for Prostate Cancers
Achievements/Awards
Attended many state and national level scientific programmes and conferences
Published research articles in various journals including Indian Journal of Nuclear Medicine, European Journal of Nuclear Medicine, and Nuclear Medicine Molecular Imaging.
Oral Presentations in annual conferences of Society of Nuclear Medicine, India and European Association of Nuclear Medicine, and others.
Reviewed multiple articles of Indian Journal of Nuclear Medicine.
Membership
Lifetime Member of Society of Nuclear Medicine, India.